Converge Bio

Series-A
converge-bio.com AI & Machine Learning Tel Aviv, Israel
Total Funding $30.5M
Latest Round $25M Series-A
Last Announced Jan 13, 2026
Investors 6 Backers
Decision Makers 6 Verified

About Converge Bio

Converge Bio is redefining the intersection of biology and artificial intelligence. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs, faster leveraging the power of Generative AI and Large Language Models (LLMs) trained on biological languages.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Series-A
Global Headquarters Tel Aviv, Israel
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website converge-bio.com
Domain Registered Date Jan 30, 2024

Social & Network Presence

X / Twitter Profile @Converge_Bio (504 followers) Created on Nov 2024
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    techcrunch.com

  2. Capital Raise

    Raised $5,500,000 · Seed

  3. Milestone

    X account created (@Converge_Bio)

    504 followers

  4. Milestone

    Website domain registered

    converge-bio.com

Investors & Backers

6
AuroraAxis Capital
Bessemer Venture Partners
Bill & Melinda Gates Foundation
Saras Capital
TLV Partners
Vintage Investment Partners

Funding History

2 Rounds
Series-A · Jan 13, 2026
$25,000,000 techcrunch.com
Seed · Nov 20, 2024
$5,500,000 Source

Founders & Leadership

3

Dov Gertz

CEO & Co-Founder

Work email & phone locked Unlock →

Iddo Weiner

CSO & Co-Founder

Work email & phone locked Unlock →

Oded Kalev

CTO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts